Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a secondary subject of discussion
A Review of Ranolazine (RANEXA) For Chronic Chest Pain
[hide all summaries]
(March 2007)
Although the FDA medical officer in charge of reviewing ranolazine recommended that ranolazine's professional product labeling display a black box warning about potential disruption in the heart's electrical cycle, the drug does not have a black box warning.
Additional Information from Public Citizen
Search results below include Additional Information from Public Citizen where your selected drug is a secondary subject of discussion